Q1 2020 BioCryst Pharmaceuticals Inc Earnings Call Transcript
Good morning, ladies and gentlemen. And welcome to the BioCryst First Quarter 2020 Earnings Call.
(Operator Instruction]
As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Mr. John Bluth at Biocryst.
Thanks, Whitney. Good morning. And welcome to BioCryst's First Quarter 2020 Corporate Update and Financial Results Conference Call. Today's press release and slides are available on our website.
Participating with me today are: CEO, Jon Stonehouse; CFO, Anthony Doyle; Chief Medical Officer, Dr. Bill Sheridan; Chief Business Officer, Megan Sniecinski; and Chief Commercial Officer, Charlie Gayer. Following our remarks, we will answer your questions.
Before we begin, please note that today's conference call will contain forward-looking statements, including those statements regarding future results, unaudited and forward-looking financial information as well as the company's
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |